Asia-Pacific Noninvasive Fat Reduction Market Forecast to 2031 - Regional Analysis - by Technology and End User

The Asia Pacific noninvasive fat reduction market was valued at US$ 415.08 million in 2023 and is projected to reach US$ 1.70 billion by 2031; it is estimated to register a CAGR of 19.4% from 2023 to 2031.

Product Approvals and Innovations Boost Asia Pacific Noninvasive Fat Reduction Market

The table below highlights the noninvasive fat reduction-centric products launched by companies operating in the market.

Date

Company Name

Product Name

Product Description

Jan-21

AbbVie, Inc.

CoolSculpting Elite

CoolSculpting Elite is a clinically proven technology to target, freeze, and eliminate treated fat cells. The product is FDA-cleared to treat visible fat bulges in nine areas of the body, including the thigh, abdomen, and flank, as well as bra fat, back fat, underneath the buttocks, upper arm, and the submental and submandibular areas.

Apr-22

VLCC

VLCC Lipo-1060

VLCC Lipo-1060 treatment uses the latest laser appliances of specific wavelengths that enable noninvasive body contouring and slimming without pain and ensure that only fat cells are eliminated with skin protection. The technology used in the treatment has been clinically proven to consistently reduce the fat contour in the abdomen and other areas of the body, with an excellent safety profile in all skin types.

Mar-23

truBody Brand:

truBody Brand is an award-winning treatment pair intended for a customized, convenient, and complete approach to fat reduction and muscle toning with only a 15-minute treatment duration. The truSculpt (formerly truSculpt iD) for fat reduction is a fast and effective combination approach, allowing practitioners and patients to provide optimal results for reducing fat and toning muscle.

Additionally, Medicis’s Liposonix is a new treatment technique that uses a high-intensity focused ultrasound device to eliminate fat beneath the skin. The company reportedly received FDA approval for noninvasive waist circumference reduction. Such innovative product approvals and launches are expected to enhance the market growth of noninvasive fat reduction during 2023 - 2031.

Asia Pacific Noninvasive Fat Reduction Market Overview

Asia Pacific region covers major countries such as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. Asia Pacific region accounts highest CAGR for the non-surgical fat reduction market. In the Asia Pacific region, China holds major share for the non-surgical fat reduction market. Rising demand for aesthetic procedures is one of the key factors that influences regional growth of non-surgical fat reduction market for the forecast period 2023-2031.

Asia Pacific Noninvasive Fat Reduction Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Noninvasive Fat Reduction Market Segmentation

The Asia Pacific noninvasive fat reduction market is categorized into technology, end user, and country.

Based on technology, the Asia Pacific noninvasive fat reduction market is categorized into cryolipolysis, laser lipolysis, ultrasound, and others. The cryolipolysis segment held the largest market share in 2023.

In terms of end user, the Asia Pacific noninvasive fat reduction market is segmented into hospitals, dermatology clinics & cosmetic clinics, and others. The dermatology clinics & cosmetic clinics segment held the largest market share in 2023.

By country, the Asia Pacific noninvasive fat reduction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific noninvasive fat reduction market share in 2023.

Cynosure LLC, Alma Lasers Ltd, Cutera Inc, Fotona, Sciton Inc, Lumenis, Venus Concept Inc, and Candela Corporation are some of the leading companies operating in the Asia Pacific noninvasive fat reduction market.